Stay updated on Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check17 days agoChange DetectedThe page has been updated to include new information about the study on Multiple Myeloma, specifically mentioning the National Cancer Institute and Multiple Myeloma Research Foundation as collaborators, and a new version revision. However, significant details about the study's treatment protocols and inclusion/exclusion criteria have been removed.SummaryDifference37%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.